CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody. - sprookjes - yvandenbroek - TriplyDB

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

http://www.wikidata.org/entity/Q30383481

about

The ongoing evolution of antibody-based treatments for Ebola virus infection.Discovering Drugs for the Treatment of Ebola Virus.

P2860

Q30235022-8000B045-4AA2-49B0-86F6-92B744136D53 Q40039706-A3F2358F-BB7D-45AE-B43A-E5B49AD2FDEC

P2860

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

http://www.wikidata.org/entity/Q30383481

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

@ast

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

@en

type

label

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

@ast

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

@en

prefLabel

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

@ast

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

@en

P1433

Q30383481-1424D154-5E56-4412-A34C-2E08E89448B3

P1476

Q30383481-8CBBABF1-372A-4326-B269-F78E2B78F821

P2093

Q30383481-0A2A34DB-D239-451C-88BA-749BA666186E

Q30383481-147B6764-7CB7-44AF-873C-AF646666E2D9

Q30383481-1C8BBF8D-7962-447D-957F-2F7D783620F3

Q30383481-309ACE82-E464-4DA7-B484-B6F46D3FE4E5

Q30383481-5C261971-8C02-4729-9663-26925B28513C

Q30383481-68CA2AFE-E8E3-4DAF-A0AD-4B6646D829FF

Q30383481-6FB2C47B-9773-4D45-8B6A-1B49DF5E4A74

Q30383481-893D3729-46B8-4D17-90BD-DB26AE7BBEE3

Q30383481-8FA24F97-D334-4176-B130-4F416467C0AD

Q30383481-91526772-6000-4433-9D70-D931212BC184

P2860

Q30383481-06AFE171-3EB4-4664-8870-285249A63955

Q30383481-0EEA95AA-C147-4B2E-AD1D-35F039541CB3

Q30383481-133AC71F-DAE3-48A0-A546-2749B352239D

Q30383481-3CB8B5A1-41BF-4D1A-959A-1E397104804B

Q30383481-49F4D17D-5BC1-4A20-9F8F-E3EAC5AFEE4A

Q30383481-58604994-F028-41F9-8200-D6CAFD6AB543

Q30383481-5A81F34F-2944-464B-8A59-A689EB4B5C3E

Q30383481-5E4CC99F-FABD-488E-BC27-D32D966DF0B6

Q30383481-5F8B6BFC-40FA-428C-A115-11CC25854137

Q30383481-6EA1DC60-4112-43F2-B239-EC38969CAA7A

P304

Q30383481-757DF8A1-1406-4FEA-B3D2-B4F1F75597C6

P31

Q30383481-CEAF3601-B081-482C-8609-7AAFFF0EACC4

P356

Q30383481-E556F238-3317-4073-9D60-45E804CB5FFF

P433

Q30383481-38E5E02C-4A7E-4782-AF51-751685261E8F

P478

Q30383481-656C9B67-FE69-4159-B2B4-DBF244051436

P577

Q30383481-BBCF862F-8819-4AF4-9080-23E7BC7864E3

P5875

Q30383481-8567A282-ED3B-421A-B3D3-2FD9972BC530

P698

Q30383481-B2E25BFD-8F73-443F-9A68-398848EB703C

P921

Q30383481-86AA63FB-5001-44DA-B71B-B94B813D16EE

P932

Q30383481-642487B7-C5B7-4F55-A5AE-AA6304D4C082

P356

19420862.2015.1127492

P1433

Monoclonal Antibodies

P1476

CHO cell production and sequence improvement in the 13C6FR1 anti-Ebola antibody.

@en

P2093

Alison Gillespie

http://www.w3.org/2001/XMLSchema#string

Brittney Livingston

http://www.w3.org/2001/XMLSchema#string

Chris Crowell

http://www.w3.org/2001/XMLSchema#string

Danielle Pace

http://www.w3.org/2001/XMLSchema#string

Dean K Pettit

http://www.w3.org/2001/XMLSchema#string

Edith Nalbandian

http://www.w3.org/2001/XMLSchema#string

James N Thomas

http://www.w3.org/2001/XMLSchema#string

Jane Ennis

http://www.w3.org/2001/XMLSchema#string

Kelly Arthur

http://www.w3.org/2001/XMLSchema#string

Ken Timmons

http://www.w3.org/2001/XMLSchema#string

P2860

Effective post-exposure treatment of Ebola infection

IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes

Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study.

Advanced antisense therapies for postexposure protection against lethal filovirus infections.

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

Variable region identical immunoglobulins differing in isotype express different paratopes.

Design of therapeutic proteins with enhanced stability.

Development and production of commercial therapeutic monoclonal antibodies in Mammalian cell expression systems: an overview of the current upstream technologies.

P304

347-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/19420862.2015.1127492

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290431671

http://www.w3.org/2001/XMLSchema#string

P698

26761424

http://www.w3.org/2001/XMLSchema#string

P921

P932

4966630

http://www.w3.org/2001/XMLSchema#string